analyzeportfolio
Nasdaq · Healthcare

TRIMBLE INC. (TRMB)

As-reported financials and SEC filings for TRIMBLE INC. The latest annual period is FY2025. The latest reported quarter is Q2 FY2026. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.

About TRIMBLE INC.

Trimble Inc. provides technology solutions and platforms that connect workflows for office professionals and field workers in industries such as construction, geospatial, natural resources, utilities, and transportation. The company offers software, cloud services, and hardware that help customers improve productivity, safety, and sustainability by integrating data and workflows across project lifecycles. Trimble serves a diverse customer base including contractors, architects, engineers, surveyors, energy companies, transportation providers, and government agencies worldwide.

Snapshot

Revenue
$3.59B
Revenue growth (YoY)
-2.6%
Net income
$424.0M
Diluted EPS
$1.76
Gross margin
69.1%
Operating margin
16.5%
Net margin
11.8%
FCF margin
10.1%
ROE
7.3%
net income / fiscal-year-end equity
P/E
35.0×
trailing when available, otherwise FY EPS
Market cap
$14.35B
Long-term debt / equity
0.24×
non-current term debt only

Fundamentals are from SEC filings for FY2025, the latest annual period (ended January 2, 2026). P/E and market cap are derived from stored market prices, last retrieved on a rolling basis and typically within the past week.

What changed at Trimble

  • Revenue fell 2.6% to $3.6B in FY2025, after a 3.0% decline the year before.
  • Operating margin is 16.5% in FY2025, +1.2 pp against 15.3% in FY2020.
  • Most recent quarter Q2 FY2026: revenue $972M, up 11.0% from Q2 FY2025.
  • Free cash flow was $361M in FY2025, 10.1% of revenue.
  • Net income fell 71.8% to $424M in FY2025.

Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.

Peer comparison

Where Trimble’s fundamentals sit among the 558 Healthcare companies. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).

Gross margin69.1%
70th percentile of 282
Operating margin16.5%
81st percentile of 399
Net margin11.8%
77th percentile of 418
FCF margin10.1%
67th percentile of 372
Revenue growth (YoY)-2.6%
23rd percentile of 538
ROE7.3%
70th percentile of 473
P/E35.0×
70th percentile of 201
Long-term debt / equity0.24×
33rd percentile of 243
Short interest3.59d
41st percentile of 557

No reported insider purchases (code P) in the last 90 days; 1 insider sale totaling $103,080. For context, about 15% of companies in the universe saw any reported insider purchase (code P) in the same window. Browse insider activity →

Percentiles describe where a figure sits among sector peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice. Short interest ranking uses days to cover from FINRA Consolidated Short Interest data; FINRA is the owner and source of that data, included at no additional charge.

Institutional ownership

Held by 2 of the superinvestors we track (plus 7 quant / multi-strat books), based on each investor’s most recent 13F; periods vary by investor (newest: Q2 2026).

Conviction investors
2
+7 quant / multi-strat
Initiated / added
6
0 new, 6 added
Reduced / exited
3
3 trimmed, 0 exited
Combined position
$355.9M
reported long value
InvestorAs ofPosition valueSharesChange
Millennium ManagementquantQ2 2026$70.7M1.4MAdded
Renaissance TechnologiesquantQ2 2026$69.4M1.4MAdded
ARK Investment ManagementQ2 2026$68.2M1.3MAdded
D. E. ShawquantQ2 2026$65.2M1.3MAdded
Point72 Asset ManagementquantQ2 2026$37.1M724.2KAdded
Gotham Asset ManagementQ2 2026$29.0M565.8KAdded
AQR Capital ManagementquantQ2 2026$8.9M176.1KReduced
Citadel AdvisorsquantQ2 2026$5.2M100.7KReduced
Two Sigma InvestmentsquantQ2 2026$2.4M47.6KReduced

From quarterly Form 13F filings, which can be up to 45 days delayed. Long US-listed positions only: excludes short positions, options, cash, bonds, and non-US holdings, so this is not a manager’s complete portfolio. Counts are of the investors we track, not all institutions. Not investment advice.

Recent insider activity

Non-derivative buys and sells (codes P/S) reported by officers, directors and 10% owners on SEC Form 4.

Buys (90d)
0
code P
Bought (90d)
code P value
Sells (90d)
1
$103K
Reported activity
Net selling
by $ value, 90d
Trade dateInsiderTypeSharesPriceValue
2026-08-04
filed 2026-08-06
Gabriel KaighamDirectorSell1.7K$60.00$103K
2026-04-16
filed 2026-04-17
SCHWARTZ MARK DAVIDSenior VP, AECOSell8.4K$67.01$566K
2026-04-16
filed 2026-04-17
SCHWARTZ MARK DAVIDSenior VP, AECOSell8.3K$67.01$555K
2026-04-14
filed 2026-04-16
PAINTER ROBERT GPresident & CEOSell7.5K$66.94$502K

Reported non-derivative purchases and sales (codes P/S) — which may be open-market or private; excludes option exercises, grants, and shares withheld for taxes. Dates shown are the trade date; a Form 4 can be filed days to years later. A sale can be routine (e.g. a pre-set 10b5-1 plan), so read individual transactions in context. From SEC Form 4. Not investment advice.

Short interest

Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.

Shares short
10.4M
settled 2026-08-14
Change vs prior
-8.2%
vs previous settlement
Days to cover
3.59
at avg daily volume
Avg daily volume
2.9M
FINRA reported
SettlementShares shortChangeDays to cover
2026-08-1410.4M-8.2%3.59
2026-07-3111.4M-8.1%4.31
2026-07-1512.4M+12.3%4.69
2026-06-3011.0M+10.2%2.91
2026-06-1510.0M+28.6%3.37
2026-05-297.8M+12.5%2.64
2026-05-156.9M+15.8%2.59
2026-04-306.0M+16.3%4.17

Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.

Income statement (as reported)

 FY2025FY2024FY2022FY2021FY2020
Revenue$3.59B$3.68B$3.80B$3.68B$3.66B
Gross profit$2.48B$2.40B$2.33B$2.11B$2.03B
Operating income$592.0M$460.7M$448.8M$510.9M$561.0M
Net income$424.0M$1.50B$311.3M$449.7M$492.7M
Diluted EPS$1.76$6.09$1.25$1.80$1.94

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Balance sheet (as reported)

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Cash flow (as reported)

 FY2025FY2024FY2022FY2021FY2020
Operating cash flow$386.2M$531.4M$597.1M$391.2M$750.5M
Capital expenditure$25.3M$33.6M$42.0M$43.2M$46.1M
Free cash flow$360.9M$497.8M$555.1M$348.0M$704.4M

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Quarterly trend (as reported)

QuarterRevenueRevenue YoYNet incomeDiluted EPS
Q2 FY2026$972.0M11.0%$-471.7M$-2.02
Q1 FY2026$939.9M11.8%$98.9M$0.42
Q4 FY2025$969.8M-1.4%$156.6M$0.65
Q3 FY2025$901.2M2.9%$111.5M$0.46
Q2 FY2025$875.7M0.6%$89.2M$0.37
Q1 FY2025$840.6M-11.8%$66.7M$0.27
Q4 FY2024$983.4M$90.2M$0.36
Q3 FY2024$875.8M$40.6M$0.16

Latest 8 reported quarters, from company XBRL filings on SEC EDGAR.

Company facts

ExchangeNasdaq
SectorHealthcare
SIC industryMeasuring & Controlling Devices, NEC
Latest annual periodFY2025 (ended January 2, 2026)
Latest reported quarterQ2 FY2026 (ended July 3, 2026)
Oldest indexed filing2018
SEC CIK864749

Selected SEC filings

10-Q2026-08-12
View on EDGAR →
10-Q2026-05-06
View on EDGAR →
8-K2026-08-12
View on EDGAR →
8-K2026-05-27
View on EDGAR →
8-K2026-05-26
View on EDGAR →
8-K2026-05-06
View on EDGAR →

Largest Healthcare peers

All Healthcare companies →

Monitor TRMB

Get an alert when Trimble files something material, see which superinvestors own it, and ask its filings a question with cited answers.

Monitor TRMB free

Includes one free filing-grounded research answer. Or check your whole portfolio, no account needed.

Data sourced from SEC EDGAR. Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.